Literature DB >> 7287231

On the mechanism of tumor "concomitant immunity".

E Gorelik, S Segal, M Feldman.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7287231     DOI： 10.1002/ijc.2910270618

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  14 in total

1.  Brain Metastases: Insights from Statistical Modeling of Size Distribution.

Authors:  M Buller; K M Chapple; C R Bird
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-02       Impact factor: 3.825

2.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

3.  Interactions between the local tumor and its metastases.

Authors:  E Gorelik; S Segal; J Shapiro; S Katzav; Y Ron; M Feldman
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

4.  Mathematical Modeling of Tumor-Tumor Distant Interactions Supports a Systemic Control of Tumor Growth.

Authors:  Sebastien Benzekry; Clare Lamont; Dominique Barbolosi; Lynn Hlatky; Philip Hahnfeldt
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

Review 5.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.

Authors:  R A De Weger; B Wilbrink; R M Moberts; D Mans; R Oskam; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Anti-inflammation induced by counter-irritation or by treatment with non-steroidal agents inhibits the growth of a tumour of non-detected immunogenicity.

Authors:  D O Sordelli; P A Fontán; R P Meiss; R A Ruggiero; O D Bustuoabad
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

8.  "Concomitant immunity" in murine tumours of non-detectable immunogenicity.

Authors:  R A Ruggiero; O D Bustuoabad; R D Bonfil; R P Meiss; C D Pasqualini
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

9.  Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.

Authors:  Mary Jo Turk; José A Guevara-Patiño; Gabrielle A Rizzuto; Manuel E Engelhorn; Shimon Sakaguchi; Alan N Houghton
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

10.  A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours.

Authors:  M Franco; O D Bustuoabad; P D di Gianni; A Goldman; C D Pasqualini; R A Ruggiero
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.